Viewing Study NCT06832904


Ignite Creation Date: 2025-12-24 @ 9:12 PM
Ignite Modification Date: 2025-12-25 @ 7:01 PM
Study NCT ID: NCT06832904
Status: RECRUITING
Last Update Posted: 2025-02-18
First Post: 2025-02-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Neoadjuvant Chemotherapy Plus Pyrotinib and Trastuzumab for HER2-positive Breast Cancer (NEOTORCH-BREAST05)
Sponsor: First Affiliated Hospital of Zhejiang University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module